10 Unforgivable Sins Of Xarelto Lawsuit

  1. last week

    Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to accomplish so may be grounds for compensation. Our lawyers are operating challenging to obtain those hurt by the drug the compensation they are entitled to.

    Although bleeding can be a common complication related with anticoagulants, it has been alleged that Xarelto is far more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, sufferers may possibly be at danger for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.

    If you or perhaps a loved a single suffered a critical bleeding occasion right after taking Xarelto, you may have legal recourse. For more info, speak to us today to possess your case reviewed, free of charge.
    Compensation Possibilities

    xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. Furthermore, they are searching for punitive damages, which are typically awarded to punish the defendant and deter other companies from acting similarly.
    Why Are Lawsuits Being Filed?

    Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

    In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

    The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
    The makers of the drug continue to market Xarelto as a protected anticoagulant option.
    Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
    Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
    xarelto compensation is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

    Visit this page for a lot more data on the alleged health risks of Xarelto.
    Multidistrict Litigation Trial Dates Set

    The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

 

or Sign Up to reply!